Botulinum toxin restores presynaptic inhibition of group Ia afferents in patients with essential tremor

Muscle and Nerve

Volumn 21, Issue 12, 1998, Pages 1701-1705

  Modugno, Nicola ^a,b   Priori, Alberto ^a   Berardelli, Alfredo ^a,b,c   Vacca, Laura ^a   Mercuri, Bruno ^b   Manfredi, Mario ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Botulinum toxin; Essential tremor; Movement disorder; Presynoptic inhibition; Reciprocal inhibition

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG USE; ESSENTIAL TREMOR; HUMAN; NERVE ENDING; PRIORITY JOURNAL; SENSORY NERVE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; ELECTRIC STIMULATION; FOREARM; H-REFLEX; HUMANS; MIDDLE AGED; NEURAL INHIBITION; NEUROMUSCULAR AGENTS; NEURONS, AFFERENT; PRESYNAPTIC TERMINALS; RADIAL NERVE; TREMOR;

EID: 0031761313     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199812)21:12<1701::AID-MUS12>3.0.CO;2-K     Document Type: Article

References (25)

1. Artieda J, Quesada P, Obeso JA: Reciprocal inhibition between forearm muscles in spastic hemiplegia. Neurology 1991; 41:286-289.
2. Aymard C, Chia L, Katz R, Lafitte C, Penicaud A: Reciprocal inhibition between wrist flexors and extensors in man: a new set of interneurones?. J Physiol (Lond) 1995;487:221-235.
3. Bain PG, Findley LJ, Thompson PD, Gresty MA, Rothwell JC, Harding AE, Marsden CD: A study of hereditary essential tremor. Brain 1994;117:805-824.
4. Berardelli A, Abbruzzese G, Bertolasi L, Cantarella G, Carella F, Currà A, De Grandis D, De Fazio G, Galardi G, Girlanda P, Livrea P, Modugno N, Priori A, Ruoppolo G, Vacca L, Manfredi M: Guidelines for the therapeutic use of botulinum toxin in movement disorders. Ital J Neurol Sci 1997;18: 261-269.
5. Berardelli A, Day BL, Marsden CD, Rothwell JC: Evidence favouring presynaptic inhibition between antagonist muscle afferents in the human forearm. J Physiol (Lond) 1987;391: 71-83.
6. Bertolasi L, Priori A, Tomelleri G, Bongiovanni LG, Fincati E, Simonati S, De Grandis D, Rizzuto N: Botulinum toxin treatment of muscle cramps: a clinical and neurophysiological study. Ann Neurol 1997;41:181-186.
7. Britton TC, Thompson PD, Day BL, Rothwell JC, Findley L, Marsden CD: Resetting of postural tremor at the wrist with mechanical stretches in Parkinson's disease, essential tremor, and in normal subjects mimicking tremor. Ann Neurol 1992; 31:507-514.
8. Fahn S, Tolosa E, Marin C: Clinical rating scale for tremor, in Jankovic J, Tolosa E, (eds): Parkinson's Disease and Movement Disorders. Baltimore-Munich, Urban & Schwarzenberg, 1988, pp 225-234.
9. Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E: Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol (Stockh) 1993;113:400-404.
10. Jankovic J, Schwartz P: Botulinum toxin treatment of tremors. Neurology 1991;41:1185-1188.
11. Jankovic J, Schwartz K, Clemence W, Aswad A, Mordaunt J: A randomized, double blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord 1996;11:250-256.
12. Jankovic J, Hallett M: Therapy with Botulinum Toxin. New York, Marcel Dekker, 1994.
13. Jankovic J, Brin M: Therapeutic use of botulinum toxin. N Engl J Med 1991;324:1186-1194.
14. Jenkins IH, Bain PG, Colebatch JG, Thompson PD, Findley LJ, Frackoviack RSJ, Marsden CD, Brooks DJ: A positron emission tomography study of essential tremor: evidence for over-activity of cerebellar connections. Ann Neurol 1993;34:82-90.
15. Kaji R, Rothwell JC, Katayama M, Ikeda T, Kubori T, Kohara N, Mezaki T, Shibasaki H, Kimura J: Tonic vibration reflex and muscle afferent block in writer's cramp. Ann Neurol 1995; 38:155-162.
16. Kaji R, Kohara N, Katayama M, Kubori T, Mezaki T, Shibasaki H: Muscle afferent block by intramuscular injection of lidocaine for the treatment of writer's cramp. Muscle Nerve 1995; 18:234-235.
17. Lelli S, Panizza M, Hallett M: Spinal cord inhibitory mechanisms in Parkinson's disease. Neurology 1991;41:553-556.
18. Mercuri B, Berardelli A, Modugno N, Vacca L, Ruggieri S, Manfredi M. Reciprocal inhibition in forearm muscles in patients with essential tremor. Muscle Nerve 1997:21:796-799.
19. Moore P: Handbook of Botulinum Toxin Treatment. Oxford, Blackwell Science, 1994.
20. Nakashima K, Rothwell JC, Day BL, Thompson PD, Shannon K, Marsden CD: Reciprocal inhibition in patients with writer's cramp and other occupational cramps, symptomatic hemidystonia and hemiparesis due to stroke. Brain 1989;112:681-697.
21. Pahwa R, Busenbark K, Swanson-Hyland EF, Dubinsky RM, Hubble JP, Gray C, Koller WC: Botulinum toxin treatment of essential head tremor. Neurology 1995;45:822-824.
22. Priori A, Polidori L, Paffetti M, Inghilleri M, Berardelli A: Functional abnormalities of spinal cord and motor cortex in patients with Huntington's disease: a study of reciprocal inhibition and of the muscular silent period evoked by transcranial stimulation. Neurosci Lett 1992;43:S91.
23. Priori A, Berardelli A, Mercuri B, Manfredi M: Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain 1995;118:801-807.
24. Rondot MD, Korn H, Scherre J: Suppression of an entire tremor by anesthetizing a selective muscular group. Arch Neurol 1968;19:421-429.
25. Rosales RL, Arimura K, Takenaga S, Osame M: Extrafusal and intrafusal muscle effects in experimental botulinum toxin A injection. Muscle Nerve 1996;10:488-496.